(MENAFNEditorial) REDWOOD CITY, Calif., April 23, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it will release financial results for the first quarter of 2018 after market close on Monday, May 7, 2018. Company management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Monday, May 7, 2018.
Investors interested in listening to the conference call may do so by dialing (866) 393-4306 for U.S. callers or (734) 385-2616 for international callers (Conference ID: 8882719), or logging into the webcast on the "Investors" section of the Company's website at www.nevro.com/investors . Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company's website.
About Nevro
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® system and Senza II™ system are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
Investor Relations Contact:
Nevro Investor Relations
Katherine Bock
(650) 433-3247
View original content with multimedia: http://www.prnewswire.com/news-releases/nevro-to-report-operating-results-for-the-first-quarter-2018-300634690.html
SOURCE Nevro Corp.
MENAFN2304201800701241ID1096760482
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.